BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Abbott DH, Dumesic DA, Levine JE. Hyperandrogenic origins of polycystic ovary syndrome - implications for pathophysiology and therapy. Expert Rev Endocrinol Metab 2019;14:131-43. [PMID: 30767580 DOI: 10.1080/17446651.2019.1576522] [Cited by in Crossref: 57] [Cited by in F6Publishing: 44] [Article Influence: 19.0] [Reference Citation Analysis]
Number Citing Articles
1 Sadeghi HM, Adeli I, Calina D, Docea AO, Mousavi T, Daniali M, Nikfar S, Tsatsakis A, Abdollahi M. Polycystic Ovary Syndrome: A Comprehensive Review of Pathogenesis, Management, and Drug Repurposing. Int J Mol Sci 2022;23:583. [PMID: 35054768 DOI: 10.3390/ijms23020583] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Dumesic DA, Hoyos LR, Chazenbalk GD, Naik R, Padmanabhan V, Abbott DH. Mechanisms of intergenerational transmission of polycystic ovary syndrome. Reproduction 2020;159:R1-R13. [PMID: 31376813 DOI: 10.1530/REP-19-0197] [Cited by in Crossref: 22] [Cited by in F6Publishing: 11] [Article Influence: 11.0] [Reference Citation Analysis]
3 Watanabe Y, Prescott M, Campbell RE, Jasoni CL. Prenatal androgenization causes expression changes of progesterone and androgen receptor mRNAs in the arcuate nucleus of female mice across development. J Neuroendocrinol 2021;:e13058. [PMID: 34748236 DOI: 10.1111/jne.13058] [Reference Citation Analysis]
4 Bourgneuf C, Bailbé D, Lamazière A, Dupont C, Moldes M, Farabos D, Roblot N, Gauthier C, Mathieu d'Argent E, Cohen-Tannoudji J, Monniaux D, Fève B, Movassat J, di Clemente N, Racine C. The Goto-Kakizaki rat is a spontaneous prototypical rodent model of polycystic ovary syndrome. Nat Commun 2021;12:1064. [PMID: 33594056 DOI: 10.1038/s41467-021-21308-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
5 Dumesic DA, Padmanabhan V, Chazenbalk GD, Abbott DH. Polycystic ovary syndrome as a plausible evolutionary outcome of metabolic adaptation. Reprod Biol Endocrinol 2022;20:12. [PMID: 35012577 DOI: 10.1186/s12958-021-00878-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
6 Zhang FF, Zhang Q, Wang YL, Wang FF, Hardiman PJ, Qu F. Intergenerational Influences between Maternal Polycystic Ovary Syndrome and Offspring: An Updated Overview. J Pediatr 2021;232:272-81. [PMID: 33482217 DOI: 10.1016/j.jpeds.2021.01.018] [Reference Citation Analysis]
7 Parker J, O’brien C, Hawrelak J, Gersh FL. Polycystic Ovary Syndrome: An Evolutionary Adaptation to Lifestyle and the Environment. IJERPH 2022;19:1336. [DOI: 10.3390/ijerph19031336] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
8 Xie Y, Xiao L, Li S. Effects of Metformin on Reproductive, Endocrine, and Metabolic Characteristics of Female Offspring in a Rat Model of Letrozole-Induced Polycystic Ovarian Syndrome With Insulin Resistance. Front Endocrinol (Lausanne) 2021;12:701590. [PMID: 34484117 DOI: 10.3389/fendo.2021.701590] [Reference Citation Analysis]
9 Chappell NR, Gibbons WE, Blesson C. Pathology of Hyperandrogenemia in the Oocyte of Polycystic Ovary Syndrome. Steroids 2022. [DOI: 10.1016/j.steroids.2022.108989] [Reference Citation Analysis]
10 Wang J, Wu D, Guo H, Li M. Hyperandrogenemia and insulin resistance: The chief culprit of polycystic ovary syndrome. Life Sci 2019;236:116940. [PMID: 31604107 DOI: 10.1016/j.lfs.2019.116940] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 11.0] [Reference Citation Analysis]
11 Ezeh U, Ezeh C, Pisarska MD, Azziz R. Menstrual dysfunction in polycystic ovary syndrome: association with dynamic state insulin resistance rather than hyperandrogenism. Fertil Steril 2021;115:1557-68. [PMID: 33602559 DOI: 10.1016/j.fertnstert.2020.12.015] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Prieto-Sánchez MT, Hernández-Peñalver AI, Sánchez-Ferrer ML, Mendiola J, Torres-Cantero AM. Anogenital distance and anti-Müllerian hormone combined improves the diagnosis of polycystic ovary syndrome. Hum Fertil (Camb) 2020;:1-9. [PMID: 32713212 DOI: 10.1080/14647273.2020.1795574] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
13 Shpakov AO. Improvement Effect of Metformin on Female and Male Reproduction in Endocrine Pathologies and Its Mechanisms. Pharmaceuticals (Basel) 2021;14:42. [PMID: 33429918 DOI: 10.3390/ph14010042] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
14 Siemienowicz KJ, Filis P, Thomas J, Fowler PA, Duncan WC, Rae MT. Hepatic Mitochondrial Dysfunction and Risk of Liver Disease in an Ovine Model of “PCOS Males”. Biomedicines 2022;10:1291. [DOI: 10.3390/biomedicines10061291] [Reference Citation Analysis]
15 Moore AM. Impaired steroid hormone feedback in polycystic ovary syndrome: Evidence from preclinical models for abnormalities within central circuits controlling fertility. Clin Endocrinol (Oxf) 2022. [PMID: 35349177 DOI: 10.1111/cen.14711] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Abbott DH, Rogers J, Dumesic DA, Levine JE. Naturally Occurring and Experimentally Induced Rhesus Macaque Models for Polycystic Ovary Syndrome: Translational Gateways to Clinical Application. Med Sci (Basel) 2019;7:E107. [PMID: 31783681 DOI: 10.3390/medsci7120107] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
17 Moghetti P, Tosi F. Insulin resistance and PCOS: chicken or egg? J Endocrinol Invest. 2021;44:233-244. [PMID: 32648001 DOI: 10.1007/s40618-020-01351-0] [Cited by in Crossref: 28] [Cited by in F6Publishing: 19] [Article Influence: 14.0] [Reference Citation Analysis]
18 Rodriguez Paris V, Edwards MC, Aflatounian A, Bertoldo MJ, Ledger WL, Handelsman DJ, Gilchrist RB, Walters KA. Pathogenesis of Reproductive and Metabolic PCOS Traits in a Mouse Model. J Endocr Soc 2021;5:bvab060. [PMID: 34056500 DOI: 10.1210/jendso/bvab060] [Reference Citation Analysis]
19 Ding H, Zhang J, Zhang F, Zhang S, Chen X, Liang W, Xie Q. Resistance to the Insulin and Elevated Level of Androgen: A Major Cause of Polycystic Ovary Syndrome. Front Endocrinol (Lausanne) 2021;12:741764. [PMID: 34745009 DOI: 10.3389/fendo.2021.741764] [Reference Citation Analysis]
20 Della Corte L, Foreste V, Barra F, Gustavino C, Alessandri F, Centurioni MG, Ferrero S, Bifulco G, Giampaolino P. Current and experimental drug therapy for the treatment of polycystic ovarian syndrome. Expert Opin Investig Drugs 2020;29:819-30. [PMID: 32543238 DOI: 10.1080/13543784.2020.1781815] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
21 Lonardo A, Mantovani A, Lugari S, Targher G. NAFLD in Some Common Endocrine Diseases: Prevalence, Pathophysiology, and Principles of Diagnosis and Management. Int J Mol Sci. 2019;20. [PMID: 31212642 DOI: 10.3390/ijms20112841] [Cited by in Crossref: 44] [Cited by in F6Publishing: 39] [Article Influence: 14.7] [Reference Citation Analysis]
22 Dinsdale NL, Crespi BJ. Endometriosis and polycystic ovary syndrome are diametric disorders. Evol Appl 2021;14:1693-715. [PMID: 34295358 DOI: 10.1111/eva.13244] [Reference Citation Analysis]
23 Dumesic DA, Abbott DH, Sanchita S, Chazenbalk GD. Endocrine-Metabolic Dysfunction in Polycystic Ovary Syndrome: an Evolutionary Perspective. Curr Opin Endocr Metab Res 2020;12:41-8. [PMID: 32363240 DOI: 10.1016/j.coemr.2020.02.013] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
24 Tyrmi JS, Arffman RK, Pujol-Gualdo N, Kurra V, Morin-Papunen L, Sliz E, Piltonen TT, Laisk T, Kettunen J, Laivuori H; FinnGen Consortium, Estonian Biobank Research Team. Leveraging Northern European population history: novel low-frequency variants for polycystic ovary syndrome. Hum Reprod 2021:deab250. [PMID: 34791234 DOI: 10.1093/humrep/deab250] [Reference Citation Analysis]
25 Sam S, Tasali E. Role of obstructive sleep apnea in metabolic risk in PCOS. Curr Opin Endocr Metab Res 2021;17:46-51. [PMID: 34368492 DOI: 10.1016/j.coemr.2021.01.002] [Reference Citation Analysis]
26 Dumesic DA, Tulberg A, Leung KL, Fisch SC, Grogan TR, Abbott DH, Naik R, Chazenbalk GD. Accelerated subcutaneous abdominal stem cell adipogenesis predicts insulin sensitivity in normal-weight women with polycystic ovary syndrome. Fertil Steril 2021;116:232-42. [PMID: 33341231 DOI: 10.1016/j.fertnstert.2020.10.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
27 Ruddenklau A, Campbell RE. Neuroendocrine Impairments of Polycystic Ovary Syndrome. Endocrinology 2019;160:2230-42. [PMID: 31265059 DOI: 10.1210/en.2019-00428] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
28 Zhu B, Chen Y, Xu F, Shen X, Chen X, Lv J, Zhang S. Androgens impair β-cell function in a mouse model of polycystic ovary syndrome by activating endoplasmic reticulum stress. Endocr Connect 2021;10:265-72. [PMID: 33543730 DOI: 10.1530/EC-20-0608] [Reference Citation Analysis]
29 Stener-Victorin E, Manti M, Fornes R, Risal S, Lu H, Benrick A. Origins and Impact of Psychological Traits in Polycystic Ovary Syndrome. Med Sci (Basel) 2019;7:E86. [PMID: 31387252 DOI: 10.3390/medsci7080086] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
30 Gourbesville C, Kerlan V, Reznik Y. Le syndrome des ovaires polykystiques : quelles nouveautés en 2019 ?: Keeping up with PCOS in 2019. Ann Endocrinol (Paris) 2019;80 Suppl 1:S29-37. [PMID: 31606059 DOI: 10.1016/S0003-4266(19)30114-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
31 Zeber-Lubecka N, Hennig EE. Genetic Susceptibility to Joint Occurrence of Polycystic Ovary Syndrome and Hashimoto's Thyroiditis: How Far Is Our Understanding? Front Immunol 2021;12:606620. [PMID: 33746952 DOI: 10.3389/fimmu.2021.606620] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
32 Anesetti G, Chávez-Genaro R. Neonatal androgenization in rats affects oocyte maturation. Reprod Sci 2021;28:2799-806. [PMID: 33825168 DOI: 10.1007/s43032-021-00559-6] [Reference Citation Analysis]
33 Steegers-Theunissen RPM, Wiegel RE, Jansen PW, Laven JSE, Sinclair KD. Polycystic Ovary Syndrome: A Brain Disorder Characterized by Eating Problems Originating during Puberty and Adolescence. Int J Mol Sci 2020;21:E8211. [PMID: 33153014 DOI: 10.3390/ijms21218211] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
34 Franks S, Hardy K. What causes anovulation in polycystic ovary syndrome? Current Opinion in Endocrine and Metabolic Research 2020;12:59-65. [DOI: 10.1016/j.coemr.2020.03.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
35 Leung KL, Sanchita S, Pham CT, Davis BA, Okhovat M, Ding X, Dumesic P, Grogan TR, Williams KJ, Morselli M, Ma F, Carbone L, Li X, Pellegrini M, Dumesic DA, Chazenbalk GD. Dynamic changes in chromatin accessibility, altered adipogenic gene expression, and total versus de novo fatty acid synthesis in subcutaneous adipose stem cells of normal-weight polycystic ovary syndrome (PCOS) women during adipogenesis: evidence of cellular programming. Clin Epigenetics 2020;12:181. [PMID: 33228780 DOI: 10.1186/s13148-020-00970-x] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
36 Abdalla MA, Shah N, Deshmukh H, Sahebkar A, Östlundh L, Al-Rifai RH, Atkin SL, Sathyapalan T. Impact of pharmacological interventions on biochemical hyperandrogenemia in women with polycystic ovary syndrome: a systematic review and meta-analysis of randomised controlled trials. Arch Gynecol Obstet 2022. [PMID: 35434762 DOI: 10.1007/s00404-022-06549-6] [Reference Citation Analysis]
37 Nautiyal H, Imam SS, Alshehri S, Ghoneim MM, Afzal M, Alzarea SI, Güven E, Al-abbasi FA, Kazmi I. Polycystic Ovarian Syndrome: A Complex Disease with a Genetics Approach. Biomedicines 2022;10:540. [DOI: 10.3390/biomedicines10030540] [Reference Citation Analysis]
38 Wu Y, Chanclón B, Micallef P, Stener-Victorin E, Wernstedt Asterholm I, Benrick A. Maternal adiponectin prevents visceral adiposity and adipocyte hypertrophy in prenatal androgenized female mice. FASEB J 2021;35:e21299. [PMID: 33715227 DOI: 10.1096/fj.202002212R] [Reference Citation Analysis]
39 Sucquart IE, Nagarkar R, Edwards MC, Rodriguez Paris V, Aflatounian A, Bertoldo MJ, Campbell RE, Gilchrist RB, Begg DP, Handelsman DJ, Padmanabhan V, Anderson RA, Walters KA. Neurokinin 3 Receptor Antagonism Ameliorates Key Metabolic Features in a Hyperandrogenic PCOS Mouse Model. Endocrinology 2021;162:bqab020. [PMID: 33522579 DOI: 10.1210/endocr/bqab020] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
40 Guo X, Puttabyatappa M, Thompson RC, Padmanabhan V. Developmental Programming: Contribution of Epigenetic Enzymes to Antral Follicular Defects in the Sheep Model of PCOS. Endocrinology 2019;160:2471-84. [PMID: 31398247 DOI: 10.1210/en.2019-00389] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
41 Cox MJ, Edwards MC, Rodriguez Paris V, Aflatounian A, Ledger WL, Gilchrist RB, Padmanabhan V, Handelsman DJ, Walters KA. Androgen Action in Adipose Tissue and the Brain are Key Mediators in the Development of PCOS Traits in a Mouse Model. Endocrinology 2020;161:bqaa061. [PMID: 32301482 DOI: 10.1210/endocr/bqaa061] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
42 Caliskan Guzelce E, Eyupoglu D, Torgutalp S, Aktoz F, Portakal O, Demirel H, Yildiz BO. Is muscle mechanical function altered in polycystic ovary syndrome? Arch Gynecol Obstet 2019;300:771-6. [PMID: 31263987 DOI: 10.1007/s00404-019-05229-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
43 Crespi B. Variation among human populations in endometriosis and PCOS A test of the inverse comorbidity model. Evol Med Public Health 2021;9:295-310. [PMID: 34659773 DOI: 10.1093/emph/eoab029] [Reference Citation Analysis]
44 Dinsdale N, Nepomnaschy P, Crespi B. The evolutionary biology of endometriosis. Evol Med Public Health 2021;9:174-91. [PMID: 33854783 DOI: 10.1093/emph/eoab008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]